{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T05:27:10Z","timestamp":1794979630679,"version":"4.9.1"},"reference-count":88,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T00:00:00Z","timestamp":1781308800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T00:00:00Z","timestamp":1787097600000},"content-version":"vor","delay-in-days":67,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002332","name":"Semmelweis University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100002332","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Crit Care"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>A dysregulated host response to infection is central to the pathophysiology of sepsis and may culminate in life-threatening organ dysfunction. Given that this process is largely characterized by concurrent pro- and anti-inflammatory activation, immunomodulatory strategies have long been explored in sepsis research. Among these, extracorporeal removal of circulating cytokines, inflammatory mediators and other soluble factors through non-specific hemoadsorption with macroporous styrene-divinylbenzene sorbents has been proposed as a potential therapeutic approach. Its adoption into clinical practice has largely been based on pathophysiological considerations rather than on evidence from large, well-designed randomized clinical trials. Over the past 15 years, most of the available evidence has been predominantly derived from small, single-center cohorts, reports from registries and heterogeneous prospective studies with substantial variability in patients\u2019 selection, timing, and treatment intensity. In addition, the precise mechanisms of action of hemoadsorption remain incompletely understood. Although several meta-analyses have attempted to synthesize the existing data, the overall quality and heterogeneity of the included studies limit the strength and reliability of their conclusions. As a result, current guideline recommendations are largely based on expert opinions rather than high-certainty evidence. This position statement aimed to provide a concise overview of the biological rationale, current evidence, and contemporary clinical practice related to hemoadsorption in critically ill patients.<\/jats:p>","DOI":"10.1186\/s13054-026-06135-1","type":"journal-article","created":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T07:26:12Z","timestamp":1781335572000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["The role of hemoadsorption in septic shock: toward a personalized approach"],"prefix":"10.1186","volume":"30","author":[{"given":"Zsolt","family":"Molnar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamas","family":"Toth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Ronco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Louis","family":"Teboul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vedran","family":"Premu\u017ei\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steffen","family":"Mitzner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"De Backer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerd","family":"Klinkmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstanty","family":"Szuldrzynski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio Silvio","family":"Taccone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriella","family":"Bottari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manu L. N. G.","family":"Malbrain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V. Marco","family":"Ranieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,13]]},"reference":[{"key":"6135_CR1","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1001\/jama.2016.0287","volume":"315","author":"M Singer","year":"2016","unstructured":"Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016;315:801. https:\/\/doi.org\/10.1001\/jama.2016.0287.","journal-title":"JAMA"},{"key":"6135_CR2","doi-asserted-by":"publisher","first-page":"2450","DOI":"10.1016\/j.immuni.2021.10.012","volume":"54","author":"T Van Der Poll","year":"2021","unstructured":"Van Der Poll T, Shankar-Hari M, Wiersinga WJ. The immunology of sepsis. Immunity. 2021;54:2450\u201364. https:\/\/doi.org\/10.1016\/j.immuni.2021.10.012.","journal-title":"Immunity"},{"key":"6135_CR3","doi-asserted-by":"publisher","unstructured":"Fajgenbaum DC, June CH. Cytokine Storm. Longo DL, editor. N Engl J Med. 2020;383:2255\u201373. https:\/\/doi.org\/10.1056\/NEJMra2026131","DOI":"10.1056\/NEJMra2026131"},{"key":"6135_CR4","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1097\/SHK.0000000000000473","volume":"45","author":"C Ince","year":"2016","unstructured":"Ince C, Mayeux PR, Nguyen T, Gomez H, Kellum JA, Ospina-Tasc\u00f3n GA, et al. Endothelium Sepsis Shock. 2016;45:259\u201370. https:\/\/doi.org\/10.1097\/SHK.0000000000000473.","journal-title":"Endothelium Sepsis Shock"},{"key":"6135_CR5","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1186\/s13613-024-01336-9","volume":"14","author":"CA Pfortmueller","year":"2024","unstructured":"Pfortmueller CA, Dabrowski W, Wise R, Van Regenmortel N, Malbrain MLNG. Fluid accumulation syndrome in sepsis and septic shock: pathophysiology, relevance and treatment\u2014a comprehensive review. Ann Intensive Care. 2024;14:115. https:\/\/doi.org\/10.1186\/s13613-024-01336-9.","journal-title":"Ann Intensive Care"},{"key":"6135_CR6","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1177\/0300060517743836","volume":"46","author":"A-M Burgdorff","year":"2018","unstructured":"Burgdorff A-M, Bucher M, Schumann J. Vasoplegia in patients with sepsis and septic shock: pathways and mechanisms. J Int Med Res. 2018;46:1303\u201310. https:\/\/doi.org\/10.1177\/0300060517743836.","journal-title":"J Int Med Res"},{"key":"6135_CR7","doi-asserted-by":"publisher","first-page":"154258","DOI":"10.1016\/j.jcrc.2023.154258","volume":"75","author":"E Antonucci","year":"2023","unstructured":"Antonucci E, Polo T, Giovini M, Girardis M, Martin-Loeches I, Nielsen ND, et al. Refractory septic shock and alternative wordings: A systematic review of literature. J Crit Care. 2023;75:154258. https:\/\/doi.org\/10.1016\/j.jcrc.2023.154258.","journal-title":"J Crit Care"},{"key":"6135_CR8","doi-asserted-by":"publisher","first-page":"7199","DOI":"10.3390\/jcm12237199","volume":"12","author":"S Mitzner","year":"2023","unstructured":"Mitzner S, Kogelmann K, Ince C, Moln\u00e1r Z, Ferrer R, Nierhaus A. Adjunctive Hemoadsorption Therapy with CytoSorb in Patients with Septic\/Vasoplegic Shock: A Best Practice Consensus Statement. J Clin Med. 2023;12:7199. https:\/\/doi.org\/10.3390\/jcm12237199.","journal-title":"J Clin Med"},{"key":"6135_CR9","doi-asserted-by":"publisher","first-page":"7044","DOI":"10.3390\/jcm13237044","volume":"13","author":"M Papp","year":"2024","unstructured":"Papp M, Ince C, Bakker J, Molnar Z. Endothelial Protection and Improved Micro- and Macrocirculation with Hemoadsorption in Critically Ill Patients. J Clin Med. 2024;13:7044. https:\/\/doi.org\/10.3390\/jcm13237044.","journal-title":"J Clin Med"},{"key":"6135_CR10","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1001\/jama.2019.5791","volume":"321","author":"CW Seymour","year":"2019","unstructured":"Seymour CW, Kennedy JN, Wang S, Chang C-CH, Elliott CF, Xu Z, et al. Derivation, Validation, and Potential Treatment Implications of Novel Clinical Phenotypes for Sepsis. JAMA. 2019;321:2003. https:\/\/doi.org\/10.1001\/jama.2019.5791.","journal-title":"JAMA"},{"key":"6135_CR11","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1007\/s00134-023-07239-w","volume":"49","author":"RBE Van Amstel","year":"2023","unstructured":"Van Amstel RBE, Kennedy JN, Scicluna BP, Bos LDJ, Peters-Sengers H, Butler JM, et al. Uncovering heterogeneity in sepsis: a comparative analysis of subphenotypes. Intensive Care Med. 2023;49:1360\u20139. https:\/\/doi.org\/10.1007\/s00134-023-07239-w.","journal-title":"Intensive Care Med"},{"key":"6135_CR12","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/s41590-023-01660-5","volume":"25","author":"EJ Giamarellos-Bourboulis","year":"2024","unstructured":"Giamarellos-Bourboulis EJ, Aschenbrenner AC, Bauer M, Bock C, Calandra T, Gat-Viks I, et al. The pathophysiology of sepsis and precision-medicine-based immunotherapy. Nat Immunol. 2024;25:19\u201328. https:\/\/doi.org\/10.1038\/s41590-023-01660-5.","journal-title":"Nat Immunol"},{"key":"6135_CR13","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1001\/jama.2025.24175","volume":"335","author":"EJ Giamarellos-Bourboulis","year":"2026","unstructured":"Giamarellos-Bourboulis EJ, Kotsaki A, Kotsamidi I, Efthymiou A, Koutsoukou V, Ehler J, et al. Precision Immunotherapy to Improve Sepsis Outcomes: The ImmunoSep Randomized Clinical Trial. JAMA. 2026;335:775. https:\/\/doi.org\/10.1001\/jama.2025.24175.","journal-title":"JAMA"},{"key":"6135_CR14","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1097\/MCC.0000000000001178","volume":"30","author":"SJ Scherger","year":"2024","unstructured":"Scherger SJ, Kalil AC. Sepsis phenotypes, subphenotypes, and endotypes: are they ready for bedside care? Curr Opin Crit Care. 2024;30:406\u201313. https:\/\/doi.org\/10.1097\/MCC.0000000000001178.","journal-title":"Curr Opin Crit Care"},{"key":"6135_CR15","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1186\/s12879-025-12048-1","volume":"25","author":"H Ma","year":"2025","unstructured":"Ma H, Di J, Xiao S, Chen L, Zhao W, Cui J. Monitoring immune cell dynamics for potential prognostic biomarker of sepsis. BMC Infect Dis. 2025;25:1765. https:\/\/doi.org\/10.1186\/s12879-025-12048-1.","journal-title":"BMC Infect Dis"},{"key":"6135_CR16","doi-asserted-by":"publisher","first-page":"e45614","DOI":"10.2196\/45614","volume":"25","author":"A Boussina","year":"2023","unstructured":"Boussina A, Wardi G, Shashikumar SP, Malhotra A, Zheng K, Nemati S. Representation Learning and Spectral Clustering for the Development and External Validation of Dynamic Sepsis Phenotypes: Observational Cohort Study. J Med Internet Res. 2023;25:e45614. https:\/\/doi.org\/10.2196\/45614.","journal-title":"J Med Internet Res"},{"key":"6135_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(26)00040-8","author":"K Reddy","year":"2026","unstructured":"Reddy K, Sinha P, Antcliffe DB, McDowell C, Bradley PA, Black L, et al. Bedside identification of subphenotypes in acute respiratory failure (PHIND): a multicentre, observational cohort study. Lancet Respir Med. 2026. https:\/\/doi.org\/10.1016\/S2213-2600(26)00040-8. S2213260026000408.","journal-title":"Lancet Respir Med"},{"key":"6135_CR18","doi-asserted-by":"publisher","first-page":"207","DOI":"10.2478\/jccm-2020-0036","volume":"6","author":"J Kovacs","year":"2020","unstructured":"Kovacs J. Hemoadsorption in Critical Care \u2013 It Is a Useful or a Harmful Technique? J Crit Care Med. 2020;6:207\u20139. https:\/\/doi.org\/10.2478\/jccm-2020-0036.","journal-title":"J Crit Care Med"},{"key":"6135_CR19","doi-asserted-by":"publisher","first-page":"44","DOI":"10.5603\/AIT.a2015.0075","volume":"47","author":"S Vandervelden","year":"2015","unstructured":"Vandervelden S, Malbrain MLNG. Initial resuscitation from severe sepsis: one size does not fit all. Anestezjol Intensywna Ter. 2015;47:44\u201355. https:\/\/doi.org\/10.5603\/AIT.a2015.0075.","journal-title":"Anestezjol Intensywna Ter"},{"key":"6135_CR20","doi-asserted-by":"publisher","first-page":"1784","DOI":"10.1007\/s00134-025-08089-4","volume":"51","author":"J Pensier","year":"2025","unstructured":"Pensier J, Fosset M, Paschold B-S, Von Wedel D, Redaelli S, Braeuer BLP, et al. Temporal stability of phenotypes of acute respiratory distress syndrome: clinical implications for early corticosteroid therapy and mortality. Intensive Care Med. 2025;51:1784\u201396. https:\/\/doi.org\/10.1007\/s00134-025-08089-4.","journal-title":"Intensive Care Med"},{"key":"6135_CR21","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1164\/rccm.201807-1419OC","volume":"199","author":"DB Antcliffe","year":"2019","unstructured":"Antcliffe DB, Burnham KL, Al-Beidh F, Santhakumaran S, Brett SJ, Hinds CJ, et al. Transcriptomic Signatures in Sepsis and a Differential Response to Steroids. From the VANISH Randomized Trial. Am J Respir Crit Care Med. 2019;199:980\u20136. https:\/\/doi.org\/10.1164\/rccm.201807-1419OC.","journal-title":"Am J Respir Crit Care Med"},{"key":"6135_CR22","doi-asserted-by":"publisher","first-page":"4450","DOI":"10.1038\/s41467-025-59643-z","volume":"16","author":"S Rajendran","year":"2025","unstructured":"Rajendran S, Xu Z, Pan W, Zang C, Siempos I, Torres L, et al. Multicenter target trial emulation to evaluate corticosteroids for sepsis stratified by predicted organ dysfunction trajectory. Nat Commun. 2025;16:4450. https:\/\/doi.org\/10.1038\/s41467-025-59643-z.","journal-title":"Nat Commun"},{"key":"6135_CR23","doi-asserted-by":"publisher","unstructured":"Prescott HC, Antonelli M, Alhazzanic W, M\u00f8ller MH, Alshamsi F, Azevedo LCP et al. Surviving Sepsis Campaign: international guidelines for management of sepsis and septic shock 2026. Intensive Care Med [Internet]. 2026 [cited 2026 Mar 23]; https:\/\/doi.org\/10.1007\/s00134-026-08361-1","DOI":"10.1007\/s00134-026-08361-1"},{"key":"6135_CR24","doi-asserted-by":"publisher","unstructured":"Brunkhorst FM, Adamzik M, Axer H, Bauer M, Bode C, Bone H-G et al. S3-Leitlinie Sepsis \u2013 Pr\u00e4vention, Diagnose, Therapie und Nachsorge \u2013 Update 2025. Med Klin - Intensivmed Notfallmedizin [Internet]. 2025 [cited 2025 Sept 26]; https:\/\/doi.org\/10.1007\/s00063-025-01317-1","DOI":"10.1007\/s00063-025-01317-1"},{"key":"6135_CR25","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1186\/s13054-022-04255-y","volume":"26","author":"D De Backer","year":"2022","unstructured":"De Backer D, Cecconi M, Chew MS, Hajjar L, Monnet X, Ospina-Tasc\u00f3n GA, et al. A plea for personalization of the hemodynamic management of septic shock. Crit Care. 2022;26:372. https:\/\/doi.org\/10.1186\/s13054-022-04255-y.","journal-title":"Crit Care"},{"key":"6135_CR26","doi-asserted-by":"publisher","unstructured":"Giamarellos-Bourboulis EJ, Kotsaki A, Kotsamidi I, Efthymiou A, Koutsoukou V, Ehler J et al. Precision Immunotherapy to Improve Sepsis Outcomes: The ImmunoSep Randomized Clinical Trial. JAMA [Internet]. 2025 [cited 2026 Feb 11]; https:\/\/doi.org\/10.1001\/jama.2025.24175","DOI":"10.1001\/jama.2025.24175"},{"key":"6135_CR27","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1093\/ndt\/gfae089","volume":"39","author":"R Bellomo","year":"2024","unstructured":"Bellomo R, Ankawi G, Bagshaw SM, Baldwin I, Basu R, Bottari G, et al. Hemoadsorption: consensus report of the 30th Acute Disease Quality Initiative workgroup. Nephrol Dial Transpl. 2024;39:1945\u201364. https:\/\/doi.org\/10.1093\/ndt\/gfae089.","journal-title":"Nephrol Dial Transpl"},{"key":"6135_CR28","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1159\/000533468","volume":"53","author":"M Ostermann","year":"2024","unstructured":"Ostermann M, Ankawi G, Cantaluppi V, Madarasu R, Dolan K, Husain-Syed F, et al. Nomenclature of Extracorporeal Blood Purification Therapies for Acute Indications: The Nomenclature Standardization Conference. Blood Purif. 2024;53:358\u201372. https:\/\/doi.org\/10.1159\/000533468.","journal-title":"Blood Purif"},{"key":"6135_CR29","doi-asserted-by":"publisher","unstructured":"Reis T, Premu\u017ei\u0107 V, Kitawara K, Noronha IL, Ronco C. Basic Mechanisms of Hemoadsorption: Incumbency for Better Clinical Utility. Blood Purif. 2025;1\u201314. https:\/\/doi.org\/10.1159\/000548120.","DOI":"10.1159\/000548120"},{"key":"6135_CR30","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1046\/j.1525-1594.2003.07289.x","volume":"27","author":"C Ronco","year":"2003","unstructured":"Ronco C, Tetta C, Mariano F, Wratten ML, Bonello M, Bordoni V, et al. Interpreting the Mechanisms of Continuous Renal Replacement Therapy in Sepsis: The Peak Concentration Hypothesis. Artif Organs. 2003;27:792\u2013801. https:\/\/doi.org\/10.1046\/j.1525-1594.2003.07289.x.","journal-title":"Artif Organs"},{"key":"6135_CR31","doi-asserted-by":"publisher","first-page":"12786","DOI":"10.3390\/ijms222312786","volume":"22","author":"T K\u00f6hler","year":"2021","unstructured":"K\u00f6hler T, Schwier E, Praxenthaler J, Kirchner C, Henzler D, Eickmeyer C. Therapeutic Modulation of the Host Defense by Hemoadsorption with CytoSorb\u00ae\u2014Basics, Indications and Perspectives\u2014A Scoping Review. Int J Mol Sci. 2021;22:12786. https:\/\/doi.org\/10.3390\/ijms222312786.","journal-title":"Int J Mol Sci"},{"key":"6135_CR32","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/s13054-023-04391-z","volume":"27","author":"A Jansen","year":"2023","unstructured":"Jansen A, Waalders NJB, Van Lier DPT, Kox M, Pickkers P. CytoSorb hemoperfusion markedly attenuates circulating cytokine concentrations during systemic inflammation in humans in vivo. Crit Care. 2023;27:117. https:\/\/doi.org\/10.1186\/s13054-023-04391-z.","journal-title":"Crit Care"},{"key":"6135_CR33","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.jtha.2023.07.020","volume":"22","author":"T Iba","year":"2024","unstructured":"Iba T, Helms J, Levi M, Levy JH. Thromboinflammation in acute injury: infections, heatstroke, and trauma. J Thromb Haemost. 2024;22:7\u201322. https:\/\/doi.org\/10.1016\/j.jtha.2023.07.020.","journal-title":"J Thromb Haemost"},{"key":"6135_CR34","doi-asserted-by":"publisher","first-page":"1359097","DOI":"10.3389\/fimmu.2024.1359097","volume":"15","author":"R Kasper","year":"2024","unstructured":"Kasper R, Rodriguez-Alfonso A, St\u00e4ndker L, Wiese S, Schneider EM. Major endothelial damage markers identified from hemadsorption filters derived from treated patients with septic shock \u2013 endoplasmic reticulum stress and bikunin may play a role. Front Immunol. 2024;15:1359097. https:\/\/doi.org\/10.3389\/fimmu.2024.1359097.","journal-title":"Front Immunol"},{"key":"6135_CR35","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s13613-024-01301-6","volume":"14","author":"T Iba","year":"2024","unstructured":"Iba T, Maier CL, Helms J, Ferrer R, Thachil J, Levy JH. Managing sepsis and septic shock in an endothelial glycocalyx-friendly way: from the viewpoint of surviving sepsis campaign guidelines. Ann Intensive Care. 2024;14:64. https:\/\/doi.org\/10.1186\/s13613-024-01301-6.","journal-title":"Ann Intensive Care"},{"key":"6135_CR36","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1186\/s13054-022-04061-6","volume":"26","author":"F Gavelli","year":"2022","unstructured":"Gavelli F, Shi R, Teboul J-L, Azzolina D, Mercado P, Jozwiak M, et al. Extravascular lung water levels are associated with mortality: a systematic review and meta-analysis. Crit Care. 2022;26:202. https:\/\/doi.org\/10.1186\/s13054-022-04061-6.","journal-title":"Crit Care"},{"key":"6135_CR37","doi-asserted-by":"publisher","first-page":"539","DOI":"10.3390\/biomedicines8120539","volume":"8","author":"C Rugg","year":"2020","unstructured":"Rugg C, Klose R, Hornung R, Innerhofer N, Bachler M, Schmid S, et al. Hemoadsorption with CytoSorb in Septic Shock Reduces Catecholamine Requirements and In-Hospital Mortality: A Single-Center Retrospective \u2018Genetic\u2019 Matched Analysis. Biomedicines. 2020;8:539. https:\/\/doi.org\/10.3390\/biomedicines8120539.","journal-title":"Biomedicines"},{"key":"6135_CR38","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1007\/s10047-017-0967-4","volume":"20","author":"S Friesecke","year":"2017","unstructured":"Friesecke S, Stecher S-S, Gross S, Felix SB, Nierhaus A. Extracorporeal cytokine elimination as rescue therapy in refractory septic shock: a prospective single-center study. J Artif Organs. 2017;20:252\u20139. https:\/\/doi.org\/10.1007\/s10047-017-0967-4.","journal-title":"J Artif Organs"},{"key":"6135_CR39","doi-asserted-by":"publisher","first-page":"294","DOI":"10.3390\/jcm13010294","volume":"13","author":"K Kogelmann","year":"2024","unstructured":"Kogelmann K, H\u00fcbner T, Dr\u00fcner M, Jarczak D. Impact of CytoSorb Hemoadsorption Therapy on Fluid Balance in Patients with Septic Shock. J Clin Med. 2024;13:294. https:\/\/doi.org\/10.3390\/jcm13010294.","journal-title":"J Clin Med"},{"key":"6135_CR40","doi-asserted-by":"publisher","first-page":"22","DOI":"10.5492\/wjccm.v10.i1.22","volume":"10","author":"R Paul","year":"2021","unstructured":"Paul R, Sathe P, Kumar S, Prasad S, Aleem M, Sakhalvalkar P. Multicentered prospective investigator initiated study to evaluate the clinical outcomes with extracorporeal cytokine adsorption device (CytoSorb\u00ae) in patients with sepsis and septic shock. World J Crit Care Med. 2021;10:22\u201334. https:\/\/doi.org\/10.5492\/wjccm.v10.i1.22.","journal-title":"World J Crit Care Med"},{"key":"6135_CR41","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.jcrc.2018.11.003","volume":"49","author":"F Hawchar","year":"2019","unstructured":"Hawchar F, L\u00e1szl\u00f3 I, \u00d6veges N, Tr\u00e1sy D, Ondrik Z, Molnar Z. Extracorporeal cytokine adsorption in septic shock: A proof of concept randomized, controlled pilot study. J Crit Care. 2019;49:172\u20138. https:\/\/doi.org\/10.1016\/j.jcrc.2018.11.003.","journal-title":"J Crit Care"},{"key":"6135_CR42","doi-asserted-by":"publisher","first-page":"2939","DOI":"10.3390\/jcm10132939","volume":"10","author":"K Kogelmann","year":"2021","unstructured":"Kogelmann K, H\u00fcbner T, Schwameis F, Dr\u00fcner M, Scheller M, Jarczak D. First Evaluation of a New Dynamic Scoring System Intended to Support Prescription of Adjuvant CytoSorb Hemoadsorption Therapy in Patients with Septic Shock. J Clin Med. 2021;10:2939. https:\/\/doi.org\/10.3390\/jcm10132939.","journal-title":"J Clin Med"},{"key":"6135_CR43","doi-asserted-by":"publisher","first-page":"R234","DOI":"10.1186\/cc2877","volume":"8","author":"GP Castelli","year":"2004","unstructured":"Castelli GP, Pognani C, Meisner M, Stuani A, Bellomi D, Sgarbi L. Procalcitonin and C-reactive protein during systemic inflammatory response syndrome, sepsis and organ dysfunction. Crit Care. 2004;8:R234. https:\/\/doi.org\/10.1186\/cc2877.","journal-title":"Crit Care"},{"key":"6135_CR44","doi-asserted-by":"publisher","first-page":"868348","DOI":"10.3389\/fimmu.2022.868348","volume":"13","author":"A Picod","year":"2022","unstructured":"Picod A, Morisson L, De Roquetaillade C, Sadoune M, Mebazaa A, Gayat E, et al. Systemic Inflammation Evaluated by Interleukin-6 or C-Reactive Protein in Critically Ill Patients: Results From the FROG-ICU Study. Front Immunol. 2022;13:868348. https:\/\/doi.org\/10.3389\/fimmu.2022.868348.","journal-title":"Front Immunol"},{"key":"6135_CR45","doi-asserted-by":"publisher","first-page":"2285","DOI":"10.3390\/jcm14072285","volume":"14","author":"D Steindl","year":"2025","unstructured":"Steindl D, Schroeder T, Krannich A, Nee J. Hemoadsorption in the Management of Septic Shock: A Systematic Review and Meta-Analysis. J Clin Med. 2025;14:2285. https:\/\/doi.org\/10.3390\/jcm14072285.","journal-title":"J Clin Med"},{"key":"6135_CR46","doi-asserted-by":"publisher","first-page":"100817","DOI":"10.1016\/j.xcrm.2022.100817","volume":"3","author":"K Leventogiannis","year":"2022","unstructured":"Leventogiannis K, Kyriazopoulou E, Antonakos N, Kotsaki A, Tsangaris I, Markopoulou D, et al. Toward personalized immunotherapy in sepsis: The PROVIDE randomized clinical trial. Cell Rep Med. 2022;3:100817. https:\/\/doi.org\/10.1016\/j.xcrm.2022.100817.","journal-title":"Cell Rep Med"},{"key":"6135_CR47","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1007\/s00134-017-4683-6","volume":"43","author":"A Rhodes","year":"2017","unstructured":"Rhodes A, Evans LE, Alhazzani W, Levy MM, Antonelli M, Ferrer R, et al. Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016. Intensive Care Med. 2017;43:304\u201377. https:\/\/doi.org\/10.1007\/s00134-017-4683-6.","journal-title":"Intensive Care Med"},{"key":"6135_CR48","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1097\/ALN.0000000000002820","volume":"131","author":"A Putzu","year":"2019","unstructured":"Putzu A, Schorer R, Lopez-Delgado JC, Cassina T, Landoni G. Blood Purification and Mortality in Sepsis and Septic Shock: A Systematic Review and Meta-analysis of Randomized Trials. Anesthesiology. 2019;131:580\u201393. https:\/\/doi.org\/10.1097\/ALN.0000000000002820.","journal-title":"Anesthesiology"},{"key":"6135_CR49","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s13613-019-0530-y","volume":"9","author":"PM Honore","year":"2019","unstructured":"Honore PM, Hoste E, Moln\u00e1r Z, Jacobs R, Joannes-Boyau O, Malbrain MLNG, et al. Cytokine removal in human septic shock: Where are we and where are we going? Ann Intensive Care. 2019;9:56. https:\/\/doi.org\/10.1186\/s13613-019-0530-y.","journal-title":"Ann Intensive Care"},{"key":"6135_CR50","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1186\/s13613-021-00905-6","volume":"11","author":"C Scharf","year":"2021","unstructured":"Scharf C, Schroeder I, Paal M, Winkels M, Irlbeck M, Zoller M, et al. Can the cytokine adsorber CytoSorb\u00ae help to mitigate cytokine storm and reduce mortality in critically ill patients? A propensity score matching analysis. Ann Intensive Care. 2021;11:115. https:\/\/doi.org\/10.1186\/s13613-021-00905-6.","journal-title":"Ann Intensive Care"},{"key":"6135_CR51","doi-asserted-by":"publisher","first-page":"10493","DOI":"10.1038\/s41598-021-89965-z","volume":"11","author":"AG Schneider","year":"2021","unstructured":"Schneider AG, Andr\u00e9 P, Scheier J, Schmidt M, Ziervogel H, Buclin T, et al. Pharmacokinetics of anti-infective agents during CytoSorb hemoadsorption. Sci Rep. 2021;11:10493. https:\/\/doi.org\/10.1038\/s41598-021-89965-z.","journal-title":"Sci Rep"},{"key":"6135_CR52","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1097\/CCM.0b013e318170b9a7","volume":"36","author":"Z-Y Peng","year":"2008","unstructured":"Peng Z-Y, Carter MJ, Kellum JA. Effects of hemoadsorption on cytokine removal and short-term survival in septic rats. Crit Care Med. 2008;36:1573\u20137. https:\/\/doi.org\/10.1097\/CCM.0b013e318170b9a7.","journal-title":"Crit Care Med"},{"key":"6135_CR53","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1159\/000351206","volume":"35","author":"SR Mitzner","year":"2013","unstructured":"Mitzner SR, Gloger M, Henschel J, Koball S. Improvement of Hemodynamic and Inflammatory Parameters by Combined Hemoadsorption and Hemodiafiltration in Septic Shock: A Case Report. Blood Purif. 2013;35:314\u20135. https:\/\/doi.org\/10.1159\/000351206.","journal-title":"Blood Purif"},{"key":"6135_CR54","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1186\/s40635-025-00819-8","volume":"13","author":"S David","year":"2025","unstructured":"David S, Rimmel\u00e9 T, Joannidis M, Girardis M, Pickkers P, Nielsen ND, et al. Knowledge gaps in extracorporeal blood purification: what would be required for its successful application in septic shock? Intensive Care Med Exp. 2025;13:118. https:\/\/doi.org\/10.1186\/s40635-025-00819-8.","journal-title":"Intensive Care Med Exp"},{"key":"6135_CR55","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s40635-025-00740-0","volume":"13","author":"NJB Waalders","year":"2025","unstructured":"Waalders NJB, Kox M, Pickkers P. Haemoadsorption to remove inflammatory mediators in sepsis: past, present, and future. Intensive Care Med Exp. 2025;13:38. https:\/\/doi.org\/10.1186\/s40635-025-00740-0.","journal-title":"Intensive Care Med Exp"},{"key":"6135_CR56","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.3390\/biomedicines13071684","volume":"13","author":"M Guarino","year":"2025","unstructured":"Guarino M, Costanzini A, Luppi F, Maritati M, Contini C, De Giorgio R, et al. Extracorporeal Cytokine Adsorption in Sepsis: Current Evidence and Future Perspectives. Biomedicines. 2025;13:1684. https:\/\/doi.org\/10.3390\/biomedicines13071684.","journal-title":"Biomedicines"},{"key":"6135_CR57","doi-asserted-by":"publisher","first-page":"107994","DOI":"10.1016\/j.rmed.2025.107994","volume":"239","author":"H Xing","year":"2025","unstructured":"Xing H, Wei Y, Zhang D, Jiang Z, Qin J, Ou S, et al. Comparing adsorptive blood purification modalities for sepsis patients: A systematic review and network meta-analysis. Respir Med. 2025;239:107994. https:\/\/doi.org\/10.1016\/j.rmed.2025.107994.","journal-title":"Respir Med"},{"key":"6135_CR58","doi-asserted-by":"publisher","unstructured":"Neyra JA, Legrand M, Tidswell MA, Al-Khafaji A, Galphin C, Rains R, et al. Polymyxin B haemoadsorption in endotoxic septic shock (Tigris): a multicentre, open-label, Bayesian, randomised, controlled, phase 3 trial. Lancet Respir Med. 2026;S2213260026000470. https:\/\/doi.org\/10.1016\/S2213-2600(26)00047-0.","DOI":"10.1016\/S2213-2600(26)00047-0"},{"key":"6135_CR59","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1007\/s00134-021-06501-3","volume":"47","author":"E Garbero","year":"2021","unstructured":"Garbero E, Livigni S, Ferrari F, Finazzi S, Langer M, Malacarne P, et al. High dose coupled plasma filtration and adsorption in septic shock patients. Results of the COMPACT-2: a multicentre, adaptive, randomised clinical trial. Intensive Care Med. 2021;47:1303\u201311. https:\/\/doi.org\/10.1007\/s00134-021-06501-3.","journal-title":"Intensive Care Med"},{"key":"6135_CR60","doi-asserted-by":"publisher","first-page":"e030139","DOI":"10.1136\/bmjopen-2019-030139","volume":"9","author":"C Gim\u00e9nez-Esparza","year":"2019","unstructured":"Gim\u00e9nez-Esparza C, Portillo-Requena C, Colomina-Climent F, Allegue-Gallego JM, Galindo-Mart\u00ednez M, Moll\u00e0-Jim\u00e9nez C, et al. The premature closure of ROMPA clinical trial: mortality reduction in septic shock by plasma adsorption. BMJ Open. 2019;9:e030139. https:\/\/doi.org\/10.1136\/bmjopen-2019-030139.","journal-title":"BMJ Open"},{"key":"6135_CR61","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s40635-022-00435-w","volume":"10","author":"LDJ Bos","year":"2022","unstructured":"Bos LDJ, Laffey JG, Ware LB, Heijnen NFL, Sinha P, Patel B, et al. Towards a biological definition of ARDS: are treatable traits the solution? Intensive Care Med Exp. 2022;10:8. https:\/\/doi.org\/10.1186\/s40635-022-00435-w.","journal-title":"Intensive Care Med Exp"},{"key":"6135_CR62","doi-asserted-by":"publisher","first-page":"e1240","DOI":"10.1097\/CCE.0000000000001240","volume":"7","author":"RD Struble","year":"2025","unstructured":"Struble RD, Arakkal AT, Cavanaugh JE, Polgreen PM, Miller AC. Evaluating Potential Missed Opportunities to Prevent, Treat, or Diagnose Sepsis: A Population-Based Retrospective Study of Insurance Claims. Crit Care Explor. 2025;7:e1240. https:\/\/doi.org\/10.1097\/CCE.0000000000001240.","journal-title":"Crit Care Explor"},{"key":"6135_CR63","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5492\/wjccm.v9.i1.1","volume":"9","author":"Y Mehta","year":"2020","unstructured":"Mehta Y, Mehta C, Kumar A, George JV, Gupta A, Nanda S, et al. Experience with hemoadsorption (CytoSorb\u00ae) in the management of septic shock patients. World J Crit Care Med. 2020;9:1\u201312. https:\/\/doi.org\/10.5492\/wjccm.v9.i1.1.","journal-title":"World J Crit Care Med"},{"key":"6135_CR64","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1038\/s44324-025-00095-w","volume":"4","author":"SN Paul","year":"2026","unstructured":"Paul SN, Nessel I, Puthucheary Z, Henson SM. Sepsis and the immunometabolic inflammatory response. Npj Metab Health Dis. 2026;4:4. https:\/\/doi.org\/10.1038\/s44324-025-00095-w.","journal-title":"Npj Metab Health Dis"},{"key":"6135_CR65","doi-asserted-by":"publisher","first-page":"2600720","DOI":"10.1080\/0886022X.2025.2600720","volume":"47","author":"R Ferrer","year":"2025","unstructured":"Ferrer R, Tyczynski B, Kreutz J, Scharf C, Thielmann M, Bellgardt M, et al. Hemoadsorption therapy in severe rhabdomyolysis: a report from the international, prospective COSMOS (CytOSorb\u00ae TreatMent of Critically ill PatientS) registry. Ren Fail. 2025;47:2600720. https:\/\/doi.org\/10.1080\/0886022X.2025.2600720.","journal-title":"Ren Fail"},{"key":"6135_CR66","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1111\/aas.14115","volume":"66","author":"M Heymann","year":"2022","unstructured":"Heymann M, Schorer R, Putzu A. Mortality and adverse events of hemoadsorption with CytoSorb \u00ae in critically ill patients: A systematic review and meta-analysis of randomized controlled trials. Acta Anaesthesiol Scand. 2022;66:1037\u201350. https:\/\/doi.org\/10.1111\/aas.14115.","journal-title":"Acta Anaesthesiol Scand"},{"key":"6135_CR67","doi-asserted-by":"publisher","first-page":"e0187015","DOI":"10.1371\/journal.pone.0187015","volume":"12","author":"D Sch\u00e4dler","year":"2017","unstructured":"Sch\u00e4dler D, Pausch C, Heise D, Meier-Hellmann A, Brederlau J, Weiler N et al. K <>Eller editor 2017 The effect of a novel extracorporeal cytokine hemoadsorption device on IL-6 elimination in septic patients: A randomized controlled trial. PLoS ONE 12 e0187015 https:\/\/doi.org\/10.1371\/journal.pone.0187015.","journal-title":"PLoS ONE"},{"key":"6135_CR68","doi-asserted-by":"publisher","first-page":"1166093","DOI":"10.3389\/fcvm.2023.1166093","volume":"10","author":"D Geisler","year":"2023","unstructured":"Geisler D, Arleth N, Grabenw\u00f6ger J, Arnold Z, Aschacher T, Winkler B, et al. Impact of CytoSorb\u00ae on interleukin-6 in cardiac surgery. Front Cardiovasc Med. 2023;10:1166093. https:\/\/doi.org\/10.3389\/fcvm.2023.1166093.","journal-title":"Front Cardiovasc Med"},{"key":"6135_CR69","doi-asserted-by":"publisher","first-page":"1628241","DOI":"10.3389\/fmed.2025.1628241","volume":"12","author":"K Lei","year":"2025","unstructured":"Lei K, Chen A, An X, Guo J, Su B, Li Y. The use of CytoSorb hemoadsorption in critically ill patients: a narrative review. Front Med. 2025;12:1628241. https:\/\/doi.org\/10.3389\/fmed.2025.1628241.","journal-title":"Front Med"},{"key":"6135_CR70","doi-asserted-by":"publisher","DOI":"10.5935\/2965-2774.20230289-en","author":"JJC Salda\u00f1a-Gastulo","year":"2023","unstructured":"Salda\u00f1a-Gastulo JJC, Llamas-Barbar\u00e1n MDR, Coronel-Chucos LG, Hurtado-Roca Y. Cytokine hemoadsorption with CytoSorb\u00ae in patients with sepsis: a systematic review and meta-analysis. Crit Care Sci [Internet]. 2023. https:\/\/doi.org\/10.5935\/2965-2774.20230289-en. [cited 2025 July 23];35. Associa\u00e7\u00e3o de Medicina Intensiva Brasileira.","journal-title":"Crit Care Sci [Internet]"},{"key":"6135_CR71","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1016\/S2213-2600(21)00177-6","volume":"9","author":"A Supady","year":"2021","unstructured":"Supady A, Weber E, Rieder M, Lother A, Niklaus T, Zahn T, et al. Cytokine adsorption in patients with severe COVID-19 pneumonia requiring extracorporeal membrane oxygenation (CYCOV): a single centre, open-label, randomised, controlled trial. Lancet Respir Med. 2021;9:755\u201362. https:\/\/doi.org\/10.1016\/S2213-2600(21)00177-6.","journal-title":"Lancet Respir Med"},{"key":"6135_CR72","doi-asserted-by":"publisher","first-page":"398","DOI":"10.3390\/jpm15090398","volume":"15","author":"A Interi\u00e1n","year":"2025","unstructured":"Interi\u00e1n A, Ramasco F, Figuerola A, M\u00e9ndez R. Frailty as an Independent Predictor of Mortality in Patients with Sepsis. J Pers Med. 2025;15:398. https:\/\/doi.org\/10.3390\/jpm15090398.","journal-title":"J Pers Med"},{"key":"6135_CR73","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1186\/s12879-024-09081-x","volume":"24","author":"C Kang","year":"2024","unstructured":"Kang C, Choi S, Jang EJ, Joo S, Jeong JH, Oh S-Y, et al. Prevalence and outcomes of chronic comorbid conditions in patients with sepsis in Korea: a nationwide cohort study from 2011 to 2016. BMC Infect Dis. 2024;24:184. https:\/\/doi.org\/10.1186\/s12879-024-09081-x.","journal-title":"BMC Infect Dis"},{"key":"6135_CR74","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.1097\/CCM.0000000000000325","volume":"42","author":"SM Opal","year":"2014","unstructured":"Opal SM, Dellinger RP, Vincent J-L, Masur H, Angus DC. The Next Generation of Sepsis Clinical Trial Designs: What Is Next After the Demise of Recombinant Human Activated Protein C?*. Crit Care Med. 2014;42:1714\u201321. https:\/\/doi.org\/10.1097\/CCM.0000000000000325.","journal-title":"Crit Care Med"},{"key":"6135_CR75","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-026-08344-2","author":"M Leone","year":"2026","unstructured":"Leone M, Myatra SN, Dugar S, Wieruszewski PM, Russell L, Evans L, et al. Clinical criteria for the definition of refractory septic shock: a joint Delphi consensus from the Society of Critical Care Medicine (SCCM) and European Society of Intensive Care Medicine (ESICM). Intensive Care Med [Internet]. 2026. https:\/\/doi.org\/10.1007\/s00134-026-08344-2. [cited 2026 Apr 22].","journal-title":"Intensive Care Med [Internet]"},{"key":"6135_CR76","doi-asserted-by":"publisher","first-page":"1670620","DOI":"10.3389\/fmed.2025.1670620","volume":"12","author":"J Gubensek","year":"2025","unstructured":"Gubensek J, Vajdic Trampuz B, Zrimsek M, Persic V. Interleukin-6 extraction ratios during prolonged CytoSorb hemoadsorption depend on procedural blood flow. Front Med. 2025;12:1670620. https:\/\/doi.org\/10.3389\/fmed.2025.1670620.","journal-title":"Front Med"},{"key":"6135_CR77","doi-asserted-by":"publisher","first-page":"c179","DOI":"10.1159\/000339789","volume":"120","author":"A Khwaja","year":"2012","unstructured":"Khwaja A. KDIGO Clinical Practice Guidelines for Acute Kidney Injury. Nephron Clin Pract. 2012;120:c179\u201384. https:\/\/doi.org\/10.1159\/000339789.","journal-title":"Nephron Clin Pract"},{"key":"6135_CR78","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1186\/s12882-025-04590-6","volume":"26","author":"T Gier","year":"2025","unstructured":"Gier T, Koball S, Marcello M, Husain-Syed F, Ram\u00edrez-Guerrero G, Reis T, et al. Insights on the practical application of the current treatment consensus in rhabdomyolysis management: a case report. BMC Nephrol. 2025;26:657. https:\/\/doi.org\/10.1186\/s12882-025-04590-6.","journal-title":"BMC Nephrol"},{"key":"6135_CR79","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2017\/3818407","volume":"2017","author":"A Berkes","year":"2017","unstructured":"Berkes A, Szikszay E, Kappelmayer J, Ker\u00e9nyi A, Szab\u00f3 T, Ujhelyi L, et al. Use of Hemadsorption in a Case of Pediatric Toxic Shock Syndrome. Case Rep Crit Care. 2017;2017:1\u20135. https:\/\/doi.org\/10.1155\/2017\/3818407.","journal-title":"Case Rep Crit Care"},{"key":"6135_CR80","doi-asserted-by":"publisher","first-page":"11309","DOI":"10.1038\/s41598-024-61658-3","volume":"14","author":"P Haselwanter","year":"2024","unstructured":"Haselwanter P, Scheiner B, Balcar L, Semmler G, Riedl-Wewalka M, Schmid M, et al. Use of the CytoSorb adsorber in patients with acute-on-chronic liver failure. Sci Rep. 2024;14:11309. https:\/\/doi.org\/10.1038\/s41598-024-61658-3.","journal-title":"Sci Rep"},{"key":"6135_CR81","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1159\/000534479","volume":"53","author":"F Albrecht","year":"2024","unstructured":"Albrecht F, Schunk S, Fuchs M, Volk T, Geisel J, Fliser D, et al. Rapid and Effective Elimination of Myoglobin with CytoSorb\u00ae Hemoadsorber in Patients with Severe Rhabdomyolysis. Blood Purif. 2024;53:88\u201395. https:\/\/doi.org\/10.1159\/000534479.","journal-title":"Blood Purif"},{"key":"6135_CR82","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/j.jointm.2025.05.001","volume":"5","author":"R Ferrer","year":"2025","unstructured":"Ferrer R, Thielmann M, Kribben A, Unglaube M, Tyczynski B, Kreutz J, et al. The international, prospective CytOSorb\u00ae treatMent Of critically ill patientS (COSMOS) registry: Interim results from the first 150 patients. J Intensive Med. 2025;5:392\u20139. https:\/\/doi.org\/10.1016\/j.jointm.2025.05.001.","journal-title":"J Intensive Med"},{"key":"6135_CR83","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.jcrc.2021.04.011","volume":"64","author":"P Schultz","year":"2021","unstructured":"Schultz P, Schwier E, Eickmeyer C, Henzler D, K\u00f6hler T. High-dose CytoSorb hemoadsorption is associated with improved survival in patients with septic shock: A retrospective cohort study. J Crit Care. 2021;64:184\u201392. https:\/\/doi.org\/10.1016\/j.jcrc.2021.04.011.","journal-title":"J Crit Care"},{"key":"6135_CR84","doi-asserted-by":"publisher","first-page":"e0688","DOI":"10.1097\/CCE.0000000000000688","volume":"4","author":"J Scheier","year":"2022","unstructured":"Scheier J, Nelson PJ, Schneider A, Colombier S, Kindgen-Milles D, Deliargyris EN, et al. Mechanistic Considerations and Pharmacokinetic Implications on Concomitant Drug Administration During CytoSorb Therapy. Crit Care Explor. 2022;4:e0688. https:\/\/doi.org\/10.1097\/CCE.0000000000000688.","journal-title":"Crit Care Explor"},{"key":"6135_CR85","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s40635-025-00716-0","volume":"13","author":"G Asgarpur","year":"2025","unstructured":"Asgarpur G, Weber F, Kiessling P, Akbari N, Stroben F, Kleikamp B, et al. Impact of hemoadsorption with CytoSorb\u00ae on meropenem and piperacillin exposure in critically ill patients in a post-CKRT setup: a single-center, retrospective data analysis. Intensive Care Med Exp. 2025;13:7. https:\/\/doi.org\/10.1186\/s40635-025-00716-0.","journal-title":"Intensive Care Med Exp"},{"key":"6135_CR86","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1007\/s00134-021-06487-y","volume":"47","author":"U Liebchen","year":"2021","unstructured":"Liebchen U, Scharf C, Zoller M, Weinelt F, Kloft C, the CytoMero collaboration team. No clinically relevant removal of meropenem by cytokine adsorber CytoSorb\u00ae in critically ill patients with sepsis or septic shock. Intensive Care Med. 2021;47:1332\u20133. https:\/\/doi.org\/10.1007\/s00134-021-06487-y.","journal-title":"Intensive Care Med"},{"key":"6135_CR87","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s13613-022-01017-5","volume":"12","author":"C Scharf","year":"2022","unstructured":"Scharf C, Weinelt F, Schroeder I, Paal M, Weigand M, Zoller M, et al. Does the cytokine adsorber CytoSorb\u00ae reduce vancomycin exposure in critically ill patients with sepsis or septic shock? a prospective observational study. Ann Intensive Care. 2022;12:44. https:\/\/doi.org\/10.1186\/s13613-022-01017-5.","journal-title":"Ann Intensive Care"},{"key":"6135_CR88","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1007\/s10047-021-01274-4","volume":"25","author":"T K\u00f6hler","year":"2022","unstructured":"K\u00f6hler T, Schwier E, Kirchner C, Winde G, Henzler D, Eickmeyer C. Hemoadsorption with CytoSorb\u00ae and the early course of linezolid plasma concentration during septic shock. J Artif Organs. 2022;25:86\u201390. https:\/\/doi.org\/10.1007\/s10047-021-01274-4.","journal-title":"J Artif Organs"}],"container-title":["Critical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13054-026-06135-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-026-06135-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-026-06135-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T15:02:55Z","timestamp":1787151775000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13054-026-06135-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,13]]},"references-count":88,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["6135"],"URL":"https:\/\/doi.org\/10.1186\/s13054-026-06135-1","relation":{},"ISSN":["1364-8535"],"issn-type":[{"value":"1364-8535","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,13]]},"assertion":[{"value":"26 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"GK has received funding for lectures for Artcline GmbH and CytoSorbents Europe GmbH and has received research grants from the German Society of Anaesthesiology and Intensive Care.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"432"}}